SCM
ANIP icon

Sterling Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Sterling Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.96K Sell
72
-2,519
-97% -$202K ﹤0.01% 2517
2026
Q1 		$199K Sell
2,591
-1,420
-35% -$111K ﹤0.01% 1179
2025
Q4 		$317K Buy
4,011
+3,967
+9,016% +$343K 0.01% 1170
2025
Q3 		$4.03K Hold
44
– – ﹤0.01% 2830
2025
Q2 		$2.87K Sell
44
-63
-59% -$4.1K ﹤0.01% 2801
2025
Q1 		$7.16K Sell
107
-80
-43% -$4.78K ﹤0.01% 1988
2024
Q4 		$10.3K Buy
187
+156
+503% +$8.96K ﹤0.01% 2145
2024
Q3 		$1.85K Buy
+31
New +$1.89K ﹤0.01% 2219

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sterling Capital Management's ANIP Position: Q2 2026 in Review

Sterling Capital Management reduced its ANI Pharmaceuticals (ANIP) stake by 97% in Q2 2026, selling an estimated $202K and leaving 72 shares worth $5.96K. The position accounts for ﹤0.01% of the portfolio, ranked #2517.

Sterling Capital Management first reported a position in ANIP in Q3 2024 and has held it in 8 quarters since. The position peaked at $317K in Q4 2025. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Sterling Capital Management held 72 shares of ANI Pharmaceuticals worth $5.96K as of Q2 2026.
  • Sterling Capital Management sold 2,519 ANI Pharmaceuticals shares in Q2 2026, an estimated $202K.
  • ANI Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2517 holding.
  • Sterling Capital Management first reported a position in ANI Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's ANI Pharmaceuticals position peaked at $317K in Q4 2025.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.